Regen BioPharma Inc. $RGBP and $RGBPP researchers have identified three new series of small molecule drugs that inhibit NR2F6, bringing the total number of these series to five. @frontpagestocks
https://finance.yahoo.com/news/regen-biopharm...00294.html #BIOTECH $BIOPHARMA #PHARMA #PENNYSTOCKS #FRONTPAGESTOCKS